Immunisation and multi-dose vials

Vaccine

Volumn 28, Issue 40, 2010, Pages 6556-6561

  Gosbell, Iain B ^a,b   Gottlieb, Thomas ^c,d   Kesson, Alison M ^e,f   Post, Jeffrey J ^g,h   Dwyer, Dominic E ^d,i  

^a UNIVERSITY OF WESTERN SYDNEY   (Australia)

^b Sydney South West Pathology Service   (Australia)

^c ANZAC Research Institute   (Australia)

^d UNIVERSITY OF SYDNEY   (Australia)

^e CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^f UNIVERSITY OF SYDNEY   (Australia)

^g PRINCE OF WALES HOSPITAL   (Australia)

^h UNIVERSITY OF NEW SOUTH WALES   (Australia)

ⁱ WESTMEAD HOSPITAL   (Australia)

Author keywords

Healthcare associated infection; Influenza; Multi dose Vials; Safety; Vaccine

Indexed keywords

ATROPINE; BENZALKONIUM CHLORIDE; BUPIVACAINE; CYANOCOBALAMIN; DEXAMETHASONE; DIPHTHERIA PERTUSSIS POLIOMYELITIS TETANUS VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; DIPHTHERIA VACCINE; ERYTHROPOIETIN; FENTANYL; GLUCOSE; HEPARIN; HISTAMINE; INFLUENZA VACCINE; LOCAL ANESTHETIC AGENT; METHYLPREDNISOLONE; MORPHINE; PROPOFOL; TETANUS TOXOID;

ABSCESS; ARTHRITIS; ARTICLE; AUSTRALIA; BACTERIAL ARTHRITIS; BLOODSTREAM INFECTION; DRUG FATALITY; DRUG FORMULATION; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNIZATION; INFECTION RISK; INFLUENZA; INFLUENZA VACCINATION; MORTALITY; MULTI DOSE VIAL; PRIORITY JOURNAL; SEPTICEMIA; VIRUS TRANSMISSION; WORLD HEALTH ORGANIZATION;

AUSTRALIA; DRUG PACKAGING; HUMANS; INFECTION CONTROL; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; MASS VACCINATION; RISK ASSESSMENT; SAFETY;

EID: 77956405258     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.07.052     Document Type: Article

References (41)

1. Feery B. One hundred years of vaccination. NSW Pub Health Bull 1997, 8(8-9):61-63.
2. Fenner F.J., Henderson D., Arita I., Jazek Z., Ladnyi I.D. Smallpox and its eradication 1988, World Health Organization, Geneva.
3. Burgess M. Immunisation: a public health success. NSW Pub Health Bull 2003, 8(14):1-4.
4. Greenberg M.E., Lai M.H., Hartel G.F., Wichems C.H., Gittleson C., Bennet J., et al. Response after one dose of a monovalent influenza A (H1N1) 2009 Vaccine-preliminary report. N Engl J Med 2009, NEJMoa0907413.
5. Fenner F.J., White D.O., Prevention Control, and eradication of viral diseases. medical virology 1994, Academic Press, San Diego, CA, p. 256-65.
6. Miller N., Medew J. Infectious disease risk in swine flu jabs. Published 21/8/2009. The Age 2009, Fairfax Media Limited, Melbourne.
7. Simon P.A., Chen R.T., Elliott J.A., Schwartz B. Outbreak of pyogenic abscesses after diphtheria and tetanus toxoids and pertussis vaccination. Ped Infect Dis J 1993, 12(5 (May)):368-371.
8. Stetler H.C., Garbe P.L., Dwyer D.M., Facklam R.R., Orenstein W.A., West G.R., et al. Outbreaks of group A streptococcal abscesses following diphtheria-tetanus toxoid-pertussis vaccination. Pediatria 1985, 75(2 (February)):299-303.
9. Greaves W.L., Hinman A.R., Facklam R.R., Allman K.C., Barrett C.L., Stetler H.C. Streptococcal abscesses following diphtheria-tetanus toxoid-pertussis vaccination. Ped Infect Dis 1982, 1(6 (November-December)):388-390.
10. Borghans J.G., Stanford J.L. Mycobacterium chelonei in abscesses after injection of diphtheria-pertussis-tetanus-polio vaccine. Am Rev Resp Dis 1973, 107(1 (January)):1-8.
11. Plueckhahn V.D., Banks J. Fatal haemolytic streptococcal septicaemia following mass inoculation with influenza vaccine. Med J Aust 1970, 1:405-411.
12. Cayton H.R., Morris C.A. Injection Site streptococcal abscesses in a clinic using disposable syringes. Mon Bull Minist Health Lab Serv 1966, 25:87.
13. Capps R.B., Sborov V., Scheiffley C.S. A syringe-transmitted epidemic of infectious hepatitis. JAMA 1948, 136:819.
14. Kellaway C.H., McCallum P., Tebbutta H. The fatalities at Bundaberg. Report of the Royal Commission. Med J Aust 1928, ii(2):38.
15. Thompson N.D., Perz J.F., Moorman A.C., Holmberg S.D. Hospital health care-associated hepatitis B and C virus transmission: United States, 1998-2008. Ann Int Med 2009, 150:33-39.
16. Samandari T., Malakmadze N., Balter S., Perz J.F., Khristova M., Swetnam L., et al. A large outbreak of hepatitis B virus infections associated with frequent injections at a physician's office. Inf Cont Hosp Epidemiol 2005, 26(9 (September)):745-750.
17. Germain J.M., Carbonne A., Thiers V., Gros H., Chastan S., Bouvet E., et al. Patient-to-patient transmission of hepatitis C virus through the use of multidose vials during general anesthesia. Inf Cont Hosp Epidemiol 2005, 26(9 (September)):789-792.
18. Krause G., Trepka M.J., Whisenhunt R.S., Katz D., Nainan O., Wiersma S.T., et al. Nosocomial transmission of hepatitis C virus associated with the use of multidose saline vials. Inf Cont Hosp Epidemiol 2003, 24(2 (February)):122-127.
19. Dumpis U., Kovalova Z., Jansons J., Cupane L., Sominskaya I., Michailova M., et al. An outbreak of HBV and HCV infection in a paediatric oncology ward: epidemiological investigations and prevention of further spread. J Med Virol 2003, 69(3 (March)):331-338.
20. Kokubo S., Horii T., Yonekawa O., Ozawa N., Mukaide M. A phylogenetic-tree analysis elucidating nosocomial transmission of hepatitis C virus in a haemodialysis unit. J Vir Hep 2002, 9(6 (November)):450-454.
21. Massari M., Petrosillo N., Ippolito G., Solforosi L., Bonazzi L., Clementi M., et al. Transmission of hepatitis C virus in a gynecological surgery setting. J Clin Microbiol 2001, 39(8 (August)):2860-2863.
22. Grohskopf L.A., Roth V.R., Feikin D.R., Arduino M.J., Carson L.A., Tokars J.I., et al. Serratia liquefaciens bloodstream infections from contamination of epoetin alfa at a hemodialysis center. N Engl J Med 2001, 344(20 (May)):1491-1497.
23. Katzenstein T.L., Jorgensen L.B., Permin H., Hansen J., Nielsen C., Machuca R., et al. Nosocomial HIV-transmission in an outpatient clinic detected by epidemiological and phylogenetic analyses. AIDS 1999, 13(13 (September)):1737-1744.
24. Kidd-Ljunggren K., Broman E., Ekvall H., Gustavsson O. Nosocomial transmission of hepatitis B virus infection through multiple-dose vials. J Hosp Infect 1999, 43(1 (September)):57-62.
25. Widell A., Christensson B., Wiebe T., Schalen C., Hansson H.B., Allander T., et al. Epidemiologic and molecular investigation of outbreaks of hepatitis C virus infection on a pediatric oncology service. Ann Int Med 1999, 130(2 (January)):130-134.
26. Hutin Y.J., Goldstein S.T., Varma J.K., O'Dair J.B., Mast E.E., Shapiro C.N., et al. An outbreak of hospital-acquired hepatitis B virus infection among patients receiving chronic hemodialysis. Inf Cont Hosp Epidemiol 1999, 20(11 (November)):731-735.
27. Archibald L.K., Ramos M., Arduino M.J., Aguero S.M., Deseda C., Banerjee S., et al. Enterobacter cloacae and Pseudomonas aeruginosa polymicrobial bloodstream infections traced to extrinsic contamination of a dextrose multidose vial. J Ped 1998, 133(5 (November)):640-644.
28. Chant K., Kociuba K., Munro R., Crone S., Quin J., Wyland M., et al. Investigation of possible patient-to-patient transmission of hepatitis c in a hospital. NSW Pub Health Bull 1994, 5(5):47-51.
29. Oren I., Hershow R.C., Ben-Porath E., Krivoy N., Goldstein N., Rishpon S., et al. A common-source outbreak of fulminant hepatitis B in a hospital. Ann Int Med 1989, 110(9 (May)):691-698.
30. Nakashima A.K., McCarthy M.A., Martone W.J., Anderson R.L. Epidemic septic arthritis caused by Serratia marcescens and associated with a benzalkonium chloride antiseptic. J Clin Microbiol 1987, 25(6 (June)):1014-1018.
31. Alter M.J., Ahtone J., Maynard J.E., Hepatitis B virus transmission associated with a multiple-dose vial in a hemodialysis unit. Ann Int Med 1983, 99(3 (September)):330-333.
32. Kothari T., Reyes M.P., Brooks N. Pseudomonas cepacia septic arthritis due to intra-articular injections of methylprednisolone. Can Med Assoc J 1977, 116(11):1230-1235.
33. Cabrera H.A., Drake M.A. An epidemic in a coronary care unit caused by Pseudomonas species. Am J Clin Pathol 1975, 64(5 (November)):700-704.
34. Inman P.M., Beck A., Brown A.E., Stanford J.L. Outbreak of injection abscesses due to Mycobacterium abscessus. Arch Dermatol 1969, 100(2 (August)):141-147.
35. Drain P.K., Nelson C.M., Lloyd J.S. Single-dose versus multi-dose vaccine vials for immunization programmes in developing countries. Bull WHO 2003, 81(10):726-731.
36. Plott R.T., Wagner R.F., Tyring S.K. Iatrogenic contamination of multidose vials in simulated use. A reassessment of current patient injection technique. Arch Dermatol 1990, 126(11 (November)):1441-1444.
37. National Centre in HIV Epidemiology and Clinical Research. 2009 Annual Surveillance Report HIV/AIDS, viral hepatitis and sexually transmissible infections in Australia. Sydney: National Centre in HIV Epidemiology and Clinical Research, University of New South Wales; 2009.
38. Australian Influenza Surveillance Report No. 24, 2010. Reporting Period: June 2010-18 June 2010. Australian Government Department of Health and Ageing; 2010. p. 1-14.
39. Adams R.J., Tucker G., Price K., Hill C.L., Appleton S.L., Wilson D.H., et al. Self-reported adverse events in health care that cause harm: a population-based survey. Med J Aust 2009, 190(9 (May)):484-488.
40. Turnour C.E., Conaty S.J., Cretikos M.A. An audit of pandemic (H1N1) 2009 influenza vaccine wastage in general practice. Med J Aust 2010, 192(9):541.
41. Australian Government Australian Institute for Health and Welfare 2009 Adult Vaccination Survey Provisional topline results for H1N1 vaccination uptake 2010, Australian Government, Canberra. Welfare AGAIfHa (Ed.).